Reeve B. Waud - 06 May 2026 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Reporting relationship: Director
Issuer ticker: ACHC
Reported as of: 06 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 May 2026, 17:01:07 UTC
Prior SEC filing: 30 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Reeve B. Waud

Key filing fact

Reeve B. Waud filed Form 4 for Acadia Healthcare Company, Inc. (ACHC) on 08 May 2026.

Key facts

This page summarizes Reeve B. Waud's Form 4 filing for Acadia Healthcare Company, Inc. (ACHC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 17:01.

Change

Previous filing in this sequence was filed on 30 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001421620 Primary reporting owner

WAUD REEVE B

Relationship: Director
Address: 4020 ASPEN GROVE DRIVE, SUITE 900, FRANKLIN
Signature: /s/ Reeve B. Waud
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACHC transaction

Common Stock

Award

Transaction value
Shares: +6,331
Change %: +11%
Price: $0.000000^*
Shares after: 66,283
Date: 06 May 2026
Ownership: Direct
Footnotes: F1

ACHC transaction

Common Stock

Award

Transaction value
Shares: +9,576
Change %: +14%
Price: $0.000000^*
Shares after: 75,859
Date: 06 May 2026
Ownership: Direct
Footnotes: F2

ACHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 653,015
Date: 06 May 2026
Ownership: See Footnotes
Footnotes: F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

Footnote F2

Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock.

Footnote F3

The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").

Footnote F4

Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.

Footnote F5

Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.